| Financial Year |
March 31 2023 |
| Monetary Funds |
932,450,807.46 |
| Held-for-trading Financial Assets |
373,103,683.74 |
| Notes Receivable |
3,049,730.00 |
| Accounts Receivable |
2,437,293,632.13 |
| Advances to Suppliers |
24,663,814.96 |
| Other Receivables |
16,596,579.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
107,683,973.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
128,308,186.77 |
| Total Current Assets |
4,023,150,407.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
30,273,154.31 |
| Investment Properties |
-- |
| Fixed Assetes |
1,246,189,227.13 |
| Under-construction Projects |
102,356,893.50 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
235,733,454.25 |
| R&D expenses |
35,582,236.75 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
47,966,222.67 |
| Deferred Income Tax Assets |
163,785,062.19 |
| Other Non-Current Assets |
25,911,904.76 |
| Sub-Total of Non-Current Assets |
2,418,614,995.81 |
| Total Assets |
6,441,765,403.41 |
| Short-Term Loans |
100,180,999.99 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
335,377,364.04 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
99,558,173.64 |
| Taxes Payable |
304,685,848.86 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
190,340,396.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,339,260.96 |
| Other Current Liabilities |
3,969,506.54 |
| Sub-Total of Current Liabilities |
1,060,390,039.02 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
95,084,689.38 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
136,844,640.95 |
| Total Liabilities |
1,197,234,679.97 |
| Paid-In Capital(Or Share Stock) |
439,516,016.00 |
| Capital Surplus |
1,191,272,455.91 |
| Surplus Reserve |
56,672,097.99 |
| LESS:Treasury Stock |
153,003,114.92 |
| Undistributed Profits |
3,265,871,925.73 |
| Minority Stockholder's Interest |
301,420,549.71 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,943,110,173.73 |
| Owner's Equity（Stockholder's Equity） |
5,244,530,723.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,441,765,403.41 |
